CARsgen Therapeutics Holdings Limited (2171.HK)
2171.HK Stock Price Chart
Explore CARsgen Therapeutics Holdings Limited interactive price chart. Choose custom timeframes to analyze 2171.HK price movements and trends.
2171.HK Company Profile
Discover essential business fundamentals and corporate details for CARsgen Therapeutics Holdings Limited (2171.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
18 Jun 2021
Employees
465.00
Website
https://www.carsgen.comCEO
Zonghai Li
Description
CARsgen Therapeutics Holdings Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies and solid tumors in China and the United States. The company is involved in developing CT053, an autologous CAR-T product candidate that is in pivotal Phase II trial for the treatment of relapsed/refractory multiple myeloma in China; CT041, an autologous CAR-T product candidate that is in Phase Ib/II clinical trial for advanced gastric/gastroesophageal junction cancer and pancreatic cancer in China, as well as in Phase Ib clinical trial for advanced gastric or pancreatic cancer in the United States; and CT011, an autologous CAR-T product candidate that is in Phase I clinical trial for patients with Glypican-3 positive advanced hepatocellular carcinoma. It is also developing CT032, an autologous CAR-T products candidate that is in Phase I/II clinical trial for the treatment of B cell Non-Hodgkin's lymphoma in China; AB011, a humanized monoclonal antibody product candidate that is in Phase I clinical trial for the treatment of CLDN18.2 positive solid tumors in China; and CT017, an autologous Glypican-3-targeted CAR-T product candidate for the treatment of hepatocellular carcinoma, as well as other product candidates for the treatment of solid tumors. The company was founded in 2014 and is headquartered in Shanghai, China.
2171.HK Financial Timeline
Browse a chronological timeline of CARsgen Therapeutics Holdings Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 14 Aug 2025
EPS came in at -$0.15 surpassing the estimated -$0.44 by +65.00%, while revenue for the quarter reached $55.84M , beating expectations by +29.86%.
Earnings released on 21 May 2025
Earnings released on 18 Mar 2025
EPS came in at -$0.86 falling short of the estimated -$0.43 by -102.50%, while revenue for the quarter reached $41.94M , missing expectations by -42.33%.
Earnings released on 31 Dec 2024
EPS came in at -$0.38 , while revenue for the quarter reached $41.94M .
Earnings released on 28 Aug 2024
EPS came in at -$0.68 falling short of the estimated -$0.28 by -142.31%, while revenue for the quarter reached $41.94M , missing expectations by -84.09%.
Earnings released on 21 May 2024
EPS came in at -$0.38 , while revenue for the quarter reached $41.94M .
Earnings released on 26 Mar 2024
EPS came in at -$0.00 surpassing the estimated -$0.97 by +99.96%.
Earnings released on 18 Mar 2024
EPS came in at -$0.00 .
Earnings released on 22 Aug 2023
EPS came in at -$0.00 surpassing the estimated -$0.50 by +99.92%.
Earnings released on 18 Aug 2023
EPS came in at -$0.00 .
Earnings released on 21 Mar 2023
EPS came in at -$0.00 surpassing the estimated -$0.97 by +99.95%.
Earnings released on 31 Dec 2022
EPS came in at -$0.00 .
Earnings released on 23 Aug 2022
EPS came in at -$0.00 surpassing the estimated -$0.84 by +99.95%.
Earnings released on 30 Jun 2022
EPS came in at -$0.00 .
Earnings released on 31 Dec 2021
EPS came in at -$0.00 , while revenue for the quarter reached $15.80K .
Earnings released on 30 Sept 2021
EPS came in at -$0.00 surpassing the estimated -$0.66 by +99.94%, while revenue for the quarter reached $15.57K .
Earnings released on 30 Jun 2021
EPS came in at -$0.01 .
Earnings released on 31 Mar 2021
EPS came in at -$0.01 surpassing the estimated -$0.55 by +97.89%.
Earnings released on 31 Dec 2020
EPS came in at -$0.00 .
Earnings released on 30 Sept 2020
EPS came in at -$0.00 .
2171.HK Stock Performance
Access detailed 2171.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.